George Clinical’s management team brings together the unique qualities that makes us a key partner in clinical research programs. Our team brings together the scientific and medical contributions as well as the operational expertise and knowledge developed through many years of working in clinical research.
Vlado Perkovic, MBBS PhD FRACP FASN
Vlado Perkovic is Executive Director of The George Institute, Australia and George Clinical, and a Professor of Medicine at The University of Sydney. He is a Staff Specialist in Nephrology at the Royal North Shore Hospital and has led the development of George Clinical, the global clinical trials arm of The George Institute. His research focus is in clinical trials and epidemiology, in particular in understanding both the cardiovascular risk associated with kidney disease and the impact of interventions that might mitigate this risk. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.
Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is a member of the National Health and Medical Research Council Academy; is Chair of the Scientific Committee of the Australasian Kidney Trials Network; and is a Fellow of the Royal Australasian College of Physicians and of the American Society of Nephrology.
Marisa Petersen, PhD
Marisa completed her pharmacy degree at the University of Sydney and continued her studies with a PhD in Clinical Pharmacology and Pharmacokinetics. She has worked for over 20 years in the pharmaceutical industry, fulfilling roles in Regulatory Affairs, Clinical Research and Project Management. Prior to joining George Clinical, Marisa was the Vice President Asia Pacific for Omnicare Clinical Research, a global CRO, taking responsibility for the delivery of trials in the Asia-Pacific region and developing a network of offices across the region to effectively service customer needs. In her current role, Marisa is focussed on sustainable growth of resources in the region and delivery of regional and global studies to the highest international standards. Marisa has a strong association with ARCS in Australia and Asia and is a member of the PIC R&D Taskforce.
Bruce Neal, MB ChB PhD FRCP FAHA
Bruce managers the Medical and Scientific Liaison Group at George Clinical, is Senior Director at The George Institute for Global Health and Professor of Medicine at the University of Sydney. Bruce has played a lead role in the design, conduct and analysis of a series of pivotal large-scale outcome trials in the field of vascular disease, and has worked extensively in the Asia-Pacific region.
Denise Clarke-Hundley, BSc
Senior Director, Operations
Denise is responsible for all the clinical operations teams in the Asia Pacific region. Denise has worked in Clinical Research Operations for more than three decades. She has been employed by organisations as varied as MD Anderson Cancer Research Institute in the USA, The Western Australian Government and large pharma. Most recently, she was responsible for the development and management of regional Clinical Operations capacity for Wyeth, overseeing staff in China, Korea, Australia, Hong Kong, Taiwan and Thailand while based in Shanghai for several years. Denise has 35 years clinical research experience, more than 10 years experience implementing early phase clinical trials across the Asia Pacific region ( China, Hong Kong, Singapore, Malaysia, Taiwan, Korea, Thailand , Australia and New Zealand) and 30+ years line management experience.
Amanda Jubb, BSc (Hons)
Associate Director, Projects
Amanda is responsible for the project management team including regional project managers who are managing the Asia Pacific components of global registration studies. Amanda has 16 years experience implementing clinical trials across the Asia Pacific region and 10 years line management experience. Previous roles include: Clinical Operations Manager, Trident Clinical Research, Clinical Research Manager- Asia Pacific, Allergan Australia Pty Ltd, Senior Clinical Research Associate – Asia, Allergan Australia Pty Ltd, Senior CRA, Omnicare Clinical Research, CRA, Omnicare Clinical Research, Regulatory and Clinical Affairs Associate, Omnicare Clinical Research.
Deborah Fox, BPharm G.Dip App. Sc. (Info)
Deb oversees all compliance, training, safety and regulatory functions. Deb has more than 20 years clinical research experience in the Pharmaceutical Industry having worked in the broader Asia Pacific region. Her previous roles and responsibilities have included project and site management, clinical operations, clinical quality assurance/auditing, management of safety reporting, compliance and training activities and line management of staff, and is supplemented by extensive prior experience as a hospital pharmacist across a wide range of therapeutic areas. Deb has worked for a variety of major pharmaceutical companies and contract research organizations.
Head of Data Management
Paul manages the data management team delivering support for the various research projects conducted; including clinical trials, observational studies and surveys. Paul has over 20 years experience with global pharmaceutical and CRO companies, focusing primarily on Data Management and Project Management. Paul has worked extensively in all phases of clinical studies, from Phase I – IV and has worked collaboratively with organizations in Europe, North America and Asia. Previously, Paul has held senior positions at Roche, Novartis, PRA International and Quintiles.
Jacqueline Thorn, PhD MBA GDip IP
Director, Business Development
Jacqueline manages the business development and proposal team at George Clinical and is the primary contact for all new business opportunities and partnerships. Jacqueline has extensive experience in business development having spent 17 years in the healthcare industry working in the biotechnology, diagnostic and pharmaceutical markets. She held various sales, marketing and business development positions and has experience in intellectual property and contracting.
Philip Gregory BSc. (Hons)
General Manager China
VPhilip has over 20 years’ experience in Pharmaceutical marketing in mainstream pharmaceutical companies, biotechnology and medical devices. He has held senior management roles in International marketing, brand and business development and strategic portfolio development. Philip has worked in several countries including the USA, UK, Japan, Australia and China and has worked in Asia for over 14 years, the last seven years in China. Philip has joined George Clinical China as General Manager to oversee the next stages in the development of George Clinical’s business and operations in China and to support the growth of our clinical research activities across the Asia Pacific Region.
Wei Liu, MD
Head Operations, China
Wei is responsible for clinical operations and quality compliance & training in China. Wei has 14 years experience in clinical study related areas in China and 4 years line management experience. Previous roles include: Clinical Research Manager, R&D, China, AstraZeneca, Medical Manager, Fresenius-Kabi Pharma, Project Manager / Senior Clinical Research Associate, Excelpharmstudies, Medical Advisor / Pharmacovigilance, Hoechst Marion Roussel.
Vinodvenkatesh Patil, MBBS
Head Operations, India
Vinod primary responsibility is to develop and oversee delivery of project management activities, DM, IT, regulatory & quality compliance and training in India. He also supports clinical and health systems research conducted by the George Institute. Vinod undertook his medical training at Karnataka University, India and has over 9 years of clinical research industry experience and 6 years of line management experience. Vinod joined George Clinical in 2009, his prior appointments have been with Biological Evans, Metropolis Clinical Research and Indegene Inc. He has worked in diverse roles as Clinical Research Operations Manager, Qualified Person Pharmacovigilance (QPPV), Team Lead – Operations and Manager – Medical Writing. His clinical trials exposure is across several therapeutic areas and in different service and business environments.